


Ask a doctor about a prescription for FUROSEMIDE Fresenius Kabi 20 mg/2 ml Injectable Solution and Perfusion Solution
Package Leaflet: Information for the User
Furosemide Fresenius Kabi 20 mg/2 ml Solution for Injection and Infusion EFG
furosemide
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
Contents of the pack
Furosemide Fresenius Kabi belongs to a group of medicines called diuretics.
Furosemide increases the amount of urine produced by your body.
Furosemide is used to remove excess fluid from the body (also called edema). Excess fluid can occur due to:
Furosemide is also used during periods when blood pressure is extremely high, which can be dangerous to health (hypertensive crises).
Do not use Furosemide Fresenius Kabi:
or if you are allergic to sulfonamides
If you are not sure if you can or cannot use this medicine, consult your doctor or pharmacist.
Warnings and precautions
Consult your doctor or nurse before starting to use Furosemide Fresenius Kabi:
or if you have diabetes
or if you have liver disease (such as cirrhosis)
or if you have gout (inflamed or painful joints) due to high levels of uric acid in the blood
or if you are taking lithium
or if your skin has high sensitivity to sunlight (photosensitivity)
If administered to premature babies, it can cause kidney stones or calcification
If any of these circumstances occur, your doctor may want to change your treatment or give you special warnings.
While using Furosemide Fresenius Kabi, your doctors may recommend that you have regular blood tests to check your sugar and uric acid levels. They may also want to check the levels of important salts like potassium and sodium in your blood. This monitoring is particularly important if you are ill or have diarrhea.
Other medicines and Furosemide Fresenius Kabi
Tell your doctor or nurse if you are using, have recently used, or might use any other medicines. This is important because some medicines should not be used with Furosemide Fresenius Kabi.
In particular, tell your doctor or pharmacist if you are taking:
or risperidone – used for the treatment of certain psychoses
or medications to lower cholesterol or lipids, such as fibrates (clofibrate, fenofibrate, or bezafibrate), as they can increase the effect of furosemide
or anti-inflammatory medications, including non-steroidal ones (such as aspirin or celecoxib), as they can reduce the effect of furosemide; high doses of pain relievers (salicylates) can increase the adverse effects of furosemide.
or injections given during operations, including tubocurarine, succinylcholine, and curare derivatives.
or phenytoin or phenobarbital – for epilepsy, as the effect of furosemide may be reduced.
or amphotericin B – used for fungal infections (if used for a prolonged period)
or organoplatins – used in some types of cancer, as furosemide can increase their adverse effects.
or medications to increase blood pressure (vasopressor amines), as they may not have an effect when taken with furosemide.
or carbamazepine – used for the treatment of epilepsy or schizophrenia, can increase the adverse effects of furosemide.
or medications that can alter heart rhythm, such as amiodarone, sotalol, dofetilide, ibutilide, as they can increase the effect of furosemide.
Using Furosemide Fresenius Kabi with food, drinks, and alcohol
It is not expected that food will affect this medicine when administered intravenously. You can eat and drink normally while taking furosemide. You do not need to change your diet unless your doctor advises you to.
Pregnancy, breastfeeding, and fertility
Furosemide should not be used during pregnancy unless there are very good medical reasons to use it.
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine.
Do not use Furosemide Fresenius Kabi if you are breastfeeding
Consult your doctor or pharmacist before using any medicine.
Driving and using machines
Furosemide Fresenius Kabi can reduce your ability to concentrate and react. If you experience these symptoms, do not drive or use machines (see section 4, "Possible side effects")
Furosemide Fresenius Kabi contains sodium
This medicine contains 3.7 mg of sodium (the main component of kitchen/table salt) per ml. This is equivalent to 0.2% of the maximum recommended daily dietary intake for an adult.
Follow exactly the administration instructions of this medicine given by your doctor or nurse. If you are unsure, consult your doctor or nurse again
Normally, a doctor or nurse will administer Furosemide Fresenius Kabi to you. You will be given:
Your doctor will decide the dose. The dose depends on your particular condition, the severity of the disease, and the time you have been treated.
In some cases, instead of injections, your doctor may recommend the administration of this medicine through continuous infusion into a vein (drip).
In elderly patients, the initial dose is usually 20 mg/day. This can be gradually increased until the desired fluid loss is achieved.
The weight loss due to fluid elimination should not exceed 1 kg of body weight per day.
If you continue to need Furosemide Fresenius Kabi, your doctor will probably recommend, as soon as possible, a change from injections to an oral form (tablets) of this medicine.
If you use more Furosemide Fresenius Kabi than you should:
If you think you have received too much medicine, inform your doctor directly.
The symptoms that could indicate you have received a too high dose are: dry mouth, increased thirst, irregular heartbeat, mood changes, muscle pain or cramps, discomfort, weakness, or unusual fatigue, weak pulse, or loss of appetite.
In case of overdose or accidental ingestion, consult the Toxicology Information Service. Telephone 91 562 04 20.
If you forget to use Furosemide Fresenius Kabi
If you think you have missed an injection, consult your doctor or nurse. Do not use a double dose to make up for forgotten doses.
If you have any other questions about the use of this medicine, consult your doctor or nurse.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them. During treatment with furosemide, the following adverse effects may appear:
Frequent
Hepatic encephalopathy in patients with hepatocellular insufficiency (symptoms include memory loss, seizures, mood changes, and coma
Uncommon (affects 1 to 10 out of every 1,000 patients):
Rare (affects 1 to 10 out of every 10,000 patients):
Very Rare (affects less than 1 in 10,000 patients):
Frequency Not Known (cannot be estimated from available data):
Also, the following may occur:
Reporting of Adverse Effects
If you experience any type of adverse effect, consult your doctor, pharmacist, or nurse, even if it is a possible adverse effect that is not listed in this prospectus. You can also report it directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Composition of Furosemide Fresenius Kabi
Appearance of the Product and Package Contents
Furosemide Fresenius Kabi is a clear and colorless or almost colorless solution.
The packaging may contain 5, 50, or 100 amber-colored ampoules with 2 ml of Furosemide Fresenius Kabi 20 mg/2 ml.
Only some package sizes may be marketed.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder:
Fresenius Kabi España, S.A.
C/ Marina 16-18, 17th floor
Torre Mapfre
E-08005 Barcelona
Tel: +34 932256580
Manufacturer:
LABESFAL – Laboratórios Almiro S.A. (Fresenius Kabi Group)
Lagedo, 3465-157 Santiago de Besteiros
Portugal
Tel: +351 232 831100
This medicine is authorized in the Member States of the European Economic Area and in the United Kingdom (Northern Ireland) under the following names:
Belgium | Furosemide Fresenius Kabi 20 mg/2 ml oplossing voor injectie/infusie Furosemide Fresenius Kabi 20 mg/2 ml solution injectable /pour perfusion Furosemide Fresenius Kabi 20 mg/2 ml Injektionslösung/ Infusionslösung |
Czech Republic | Furosemid Kabi |
Finland | Furosemide Fresenius Kabi 10 mg/ml injektio-/infuusioneste |
Ireland | Furosemide 20mg/2ml solution for injection/infusion |
Portugal | Furosemida Fresenius Kabi 20mg/2ml solução injectável ou para perfusão |
Poland | Furosemid Kabi |
Netherlands | Furosemide Fresenius Kabi 20 mg/2 ml oplossing voor injectie/infusie |
Slovakia | Furosemid Kabi 20 mg/ 2 ml , injekcný /infúzny roztok |
Spain | Furosemida Fresenius Kabi 20 mg/2 ml solución inyectable y para perfusión EFG |
United Kingdom (Northern Ireland) | Furosemide 20mg/2ml solution for injection/infusion |
Date of Last Revision of this Prospectus: 05/2023
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/.
---------------------------------------------------------------------------------------------------
This information is intended for healthcare professionals:
Administration
The intravenous administration of furosemide should be slow; the speed should not exceed 4 mg per minute and should never be given in association with other medications in the same syringe.
Intramuscular administration should be restricted to exceptional cases where oral or intravenous administration is not possible. It should be noted that intramuscular injection is not suitable for the treatment of acute conditions such as pulmonary edema.
The recommended initial dose in adults and adolescents over 15 years is 20 to 40 mg (1 or 2 ampoules) administered intravenously (or intramuscularly in exceptional cases); the maximum dose varies depending on individual response. If higher doses are needed, they should be administered in 20 mg increments and not more frequently than every 2 hours.
In adults, the recommended maximum dose of furosemide is 1,500 mg.
Incompatibilities
Furosemide can be mixed with neutral and weakly alkaline solutions with a pH between 7 and 10, such as 0.9% sodium chloride and Ringer's solution.
Furosemide should not be mixed with strong acid solutions (pH below 5.5), such as solutions with ascorbic acid, noradrenaline, and adrenaline, due to the risk of precipitation.
If the product contains visible particles, it should not be used.
Single-use product. Discard any remaining content after use.
Product validity period: 3 years.
After the first opening, the product should be used immediately.
After dilution:
Physical and chemical stability is guaranteed for 24 hours at 25°C and protected from light.
The product should be used immediately from a microbiological point of view. If not used immediately, the use time, storage, and conditions prior to use are the responsibility of the user and should not normally exceed 24 hours at a temperature between 2°C and 8°C, unless the solution has been prepared in controlled and validated aseptic conditions.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for FUROSEMIDE Fresenius Kabi 20 mg/2 ml Injectable Solution and Perfusion Solution – subject to medical assessment and local rules.